Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available-Reference-Cited by-同舟云学术

Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available

Published:2019-07-18 Issue:2 Volume:12 Page:115-124
ISSN:2070-4933
Container-title:FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology
language:
Short-container-title:Farmakoèkonomika

Author:

Gorkavenko F. V.¹^ORCID,Nikitina A. V.¹^ORCID,Saibel’ E. S.¹^ORCID,Avksent’eva M. V.²^ORCID,Sura M. V.¹^ORCID,Fedyaev D. V.³^ORCID

Affiliation:

1. Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

2. Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation; Research Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget Institution; Sechenov First Moscow State Medical University

3. Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation; Research Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget Institution; Russian Presidential Academy of National Economy and Public Administration, Federal State Educational Institution of Higher Professional Education

Publisher

IRBIS

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic analysis of the dynamics of procurement of drugs based on monoclonal antibodies and biosimilars: trends and prospects;Farmaciya (Pharmacy);2024-08-10

2. Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2023-11-28